Creative Planning - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
Creative Planning ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$216,000
+9.6%
13,202
-5.8%
0.00%
Q2 2022$197,000
-60.9%
14,012
-32.7%
0.00%
-100.0%
Q1 2022$504,000
+50.9%
20,815
+45.7%
0.00%0.0%
Q4 2021$334,000
+44.0%
14,290
+2.4%
0.00%
Q3 2021$232,000
-36.1%
13,956
-6.3%
0.00%
-100.0%
Q2 2021$363,000
-9.9%
14,891
-4.7%
0.00%0.0%
Q1 2021$403,000
-74.7%
15,631
-47.5%
0.00%
-75.0%
Q4 2020$1,591,000
+44.8%
29,753
+11.7%
0.00%
+33.3%
Q3 2020$1,099,000
+95.2%
26,648
+129.3%
0.00%
+50.0%
Q2 2020$563,000
-2.9%
11,622
-15.3%
0.00%0.0%
Q1 2020$580,000
-55.0%
13,722
-54.4%
0.00%
-50.0%
Q4 2019$1,289,000
+8.0%
30,122
-9.1%
0.00%0.0%
Q3 2019$1,193,000
+29.8%
33,141
-3.6%
0.00%
+33.3%
Q2 2019$919,000
-0.3%
34,366
+0.1%
0.00%0.0%
Q1 2019$922,000
+59.8%
34,338
-3.7%
0.00%
+50.0%
Q4 2018$577,000
-6.6%
35,658
+19.7%
0.00%0.0%
Q3 2018$618,000
-52.2%
29,782
-64.8%
0.00%
-60.0%
Q2 2018$1,292,000
-20.7%
84,607
+16.6%
0.01%
-28.6%
Q1 2018$1,630,000
-25.1%
72,534
+0.3%
0.01%
-22.2%
Q4 2017$2,177,000
+20.9%
72,314
+51.2%
0.01%
+12.5%
Q3 2017$1,801,000
+159.1%
47,811
+91.9%
0.01%
+100.0%
Q2 2017$695,000
-14.9%
24,915
+4.9%
0.00%0.0%
Q1 2017$817,000
-10.8%
23,756
-25.2%
0.00%
-33.3%
Q4 2016$916,000
+137.3%
31,756
+161.8%
0.01%
+200.0%
Q3 2016$386,000
+55.6%
12,131
+54.5%
0.00%0.0%
Q2 2016$248,000
+56.0%
7,852
+37.7%
0.00%
+100.0%
Q1 2016$159,000
-18.9%
5,702
+3.6%
0.00%
-50.0%
Q4 2015$196,000
+59.3%
5,502
+47.6%
0.00%
+100.0%
Q3 2015$123,000
+7.0%
3,727
+5.7%
0.00%0.0%
Q1 2015$115,000
+2.7%
3,5250.0%0.00%0.0%
Q4 2014$112,000
-30.9%
3,525
-46.0%
0.00%
-50.0%
Q3 2014$162,000
+102.5%
6,525
+85.1%
0.00%
+100.0%
Q2 2014$80,000
-82.3%
3,525
-83.8%
0.00%
-85.7%
Q1 2014$452,000
+693.0%
21,825
+848.9%
0.01%
+600.0%
Q4 2013$57,000
-9.5%
2,3000.0%0.00%0.0%
Q3 2013$63,000
+1160.0%
2,300
+666.7%
0.00%
Q2 2013$5,0003000.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Sio Capital Management, LLC 563,200$16,243,0009.48%
Avoro Capital Advisors LLC 1,486,460$42,870,0008.66%
Baker Brothers Advisors 25,819,768$744,642,0007.30%
SECTORAL ASSET MANAGEMENT INC 1,176,543$33,932,0003.76%
HARVEY CAPITAL MANAGEMENT INC 251,825$7,262,0003.38%
ACUTA CAPITAL PARTNERS, LLC 300,000$8,652,0003.22%
Palo Alto Investors LP 1,532,030$44,184,0002.52%
Ghost Tree Capital, LLC 350,000$10,094,0002.43%
EMORY UNIVERSITY 76,121$2,195,0002.16%
WEATHERBIE CAPITAL, LLC 576,784$16,634,0002.09%
View complete list of ACADIA PHARMACEUTICALS INC shareholders